Clonal Hematopoiesis–Driver DNMT3A Mutations Alter Immune Cells in Heart Failure
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clonal Hematopoiesis–Driver DNMT3A Mutations Alter Immune Cells in Heart Failure
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 128, Issue 2, Pages 216-228
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-11-06
DOI
10.1161/circresaha.120.317104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The evolutionary dynamics and fitness landscape of clonal hematopoiesis
- (2020) Caroline J. Watson et al. SCIENCE
- Multifaceted deregulation of gene expression and protein synthesis with age
- (2020) Aleksandra S. Anisimova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging
- (2019) Zsofia Turi et al. Aging-US
- Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients
- (2019) Christine R.C. Zhang et al. EXPERIMENTAL HEMATOLOGY
- Clonal hematopoiesis, aging, and cardiovascular diseases
- (2019) Evangelia Pardali et al. EXPERIMENTAL HEMATOLOGY
- Lineage restriction analyses in CHIP indicate myeloid bias forTET2and multipotent stem cell origin forDNMT3A
- (2018) Manuel Buscarlet et al. BLOOD
- CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular DiseaseNovelty and Significance
- (2018) Soichi Sano et al. CIRCULATION RESEARCH
- Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
- (2018) Soichi Sano et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The human heart contains distinct macrophage subsets with divergent origins and functions
- (2018) Geetika Bajpai et al. NATURE MEDICINE
- Myeloid cell contributions to cardiovascular health and disease
- (2018) Matthias Nahrendorf NATURE MEDICINE
- Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
- (2018) Joseph A. Fraietta et al. NATURE
- Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure
- (2018) Lena Dorsheimer et al. JAMA Cardiology
- Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies
- (2017) Paul M Maciocia et al. NATURE MEDICINE
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
- (2017) José J. Fuster et al. SCIENCE
- Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
- (2017) Sara Santagata et al. Oncotarget
- Cell Competition and Its Role in the Regulation of Cell Fitness from Development to Cancer
- (2016) Aida Di Gregorio et al. DEVELOPMENTAL CELL
- Control of T cell antigen reactivity via programmed TCR downregulation
- (2016) Alena M Gallegos et al. NATURE IMMUNOLOGY
- Ribosomal Protein L13a Deficiency in Macrophages Promotes Atherosclerosis by Limiting Translation Control-Dependent Retardation of Inflammation
- (2014) Abhijit Basu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcription factor interplay in T helper cell differentiation
- (2013) C. M. Evans et al. Briefings in Functional Genomics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now